HER2 is rarely expressed in normal ovarian epithelial cells, but is highly positive in epithelial ovarian cancers, including 45.5% of mucinous carcinomas, 41.7% of clear cell carcinomas, and 17.5% of serous carcinomas (19). This evidence concerns the gene ERBB2 and mucinous adenocarcinoma.